190 related articles for article (PubMed ID: 8151408)
1. Use and limitations of metabolic tracers labeled with positron-emitting radionuclides in the identification of viable myocardium.
Bergmann SR
J Nucl Med; 1994 Apr; 35(4 Suppl):15S-22S. PubMed ID: 8151408
[TBL] [Abstract][Full Text] [Related]
2. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
[TBL] [Abstract][Full Text] [Related]
3. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography.
Gropler RJ; Geltman EM; Sampathkumaran K; Pérez JE; Schechtman KB; Conversano A; Sobel BE; Bergmann SR; Siegel BA
J Am Coll Cardiol; 1993 Nov; 22(6):1587-97. PubMed ID: 8227825
[TBL] [Abstract][Full Text] [Related]
4. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Visser FC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
[TBL] [Abstract][Full Text] [Related]
5. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
[TBL] [Abstract][Full Text] [Related]
6. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
Schelbert HR
Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
[No Abstract] [Full Text] [Related]
7. [Imaging of myocardial perfusion and metabolism with positron emission tomography].
Ishida Y; Fukuchi K; Oka M; Sagoh M; Miyake Y; Hasimoto N
Nihon Rinsho; 1998 Mar; 56(3):813-23. PubMed ID: 9549377
[TBL] [Abstract][Full Text] [Related]
8. Myocardial metabolic changes in hypertrophic cardiomyopathy.
Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
[TBL] [Abstract][Full Text] [Related]
9. Positron tomography and myocardial metabolism: an overview.
Sobel BE
Circulation; 1985 Nov; 72(5 Pt 2):IV22-30. PubMed ID: 3931935
[No Abstract] [Full Text] [Related]
10. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
Tamaki N; Ohtani H; Yonekura Y; Shindo M; Nohara R; Kambara H; Kawai C; Hirata K; Ban T; Konishi J
J Cardiol; 1992; 22(2-3):283-93. PubMed ID: 1339787
[TBL] [Abstract][Full Text] [Related]
11. Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction.
Rubin PJ; Lee DS; Dávila-Román VG; Geltman EM; Schechtman KB; Bergmann SR; Gropler RJ
Am J Cardiol; 1996 Dec; 78(11):1230-5. PubMed ID: 8960580
[TBL] [Abstract][Full Text] [Related]
12. [Positron emission tomography (PET): a useful tool for the assessment of cardiac metabolism].
Alexánderson E; Gómez-Martín D; Benito I; Ruíz-Ramírez L; Ricalde A; Meave A
Arch Cardiol Mex; 2004; 74(3):220-8. PubMed ID: 15559875
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography in the diagnosis and management of coronary artery disease.
Bratton NG
J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography in cardiovascular disease.
Beanlands R
Can J Cardiol; 1996 Oct; 12(10):875-83. PubMed ID: 9191475
[TBL] [Abstract][Full Text] [Related]
15. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism.
Gropler RJ; Geltman EM; Sampathkumaran K; Pérez JE; Moerlein SM; Sobel BE; Bergmann SR; Siegel BA
J Am Coll Cardiol; 1992 Sep; 20(3):569-77. PubMed ID: 1512335
[TBL] [Abstract][Full Text] [Related]
16. Cardiac positron tomography: current status and future directions.
Geltman EM; Roberts R; Sobel BE
Herz; 1980 Apr; 5(2):107-19. PubMed ID: 6970158
[TBL] [Abstract][Full Text] [Related]
17. [Positron-emission tomography (PET) in the evaluation of metabolic processes in the myocardium].
Haubold-Reuter B; Haldemann R; Amann F; Turina J; Reist W; Leenders K; von Schulthess GK
Schweiz Med Wochenschr; 1992 Jan; 122(1-2):14-21. PubMed ID: 1594901
[TBL] [Abstract][Full Text] [Related]
18. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction.
Go RT; MacIntyre WJ; Cook SA; Neumann DR; Brunken RC; Saha GB; Underwood DA; Marwick TH; Chen EQ; King JL; Khandekar S
J Nucl Cardiol; 1996; 3(2):96-104. PubMed ID: 8799234
[TBL] [Abstract][Full Text] [Related]
19. Cardiac metabolism: a technical spectrum of modalities including positron emission tomography, single-photon emission computed tomography, and magnetic resonance spectroscopy.
Valkema R; van Eck-Smit BL; van der Wall EE
J Nucl Cardiol; 1994; 1(6):546-60. PubMed ID: 9420749
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of myocardial circulation and metabolism using positron CT].
Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A
J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
